Boston Technology Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Boston Technology Review.

Press releases published on September 30, 2026

Sep. 30, 2026

Capital Advisors Group Launches Lenteris Advisors to Expand Debt Financing Services

Indeterminate EIN Presswire

Sep. 30, 2026

ReviveHealth Marks Next Phase of Its Healthcare AI Investment with Innovation Hub Ribbon Cutting

Indeterminate EIN Presswire

Sep. 30, 2026

Joined Bio Introduces Nova, an AI Assistant That Lets Participants Ask Questions About Their Own Health Records

Indeterminate EIN Presswire

Sep. 30, 2026

Jenny McCarthy Begins Therapeutic Plasma Exchange Journey to Address Mold Toxicity and Environmental Toxins

Indeterminate GlobeNewswire

Sep. 30, 2026

Crosslist, Leading Software Tool For Online Sellers, Unveils Best Practices for Integrating SaaS Solutions with WooCommerce

Indeterminate GlobeNewswire

Sep. 30, 2026

Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 30, 2026

Automatic Securities Disposition Plan Adopted by Xanadu Chief Operating Officer

Indeterminate GlobeNewswire

Sep. 30, 2026

Oculis Announces Resignation of Lionel Carnot from Board of Directors

Indeterminate GlobeNewswire

Sep. 30, 2026

Bright Minds Biosciences to Participate in the 2026 FPWR Research Symposium and PWS Family Conference

Indeterminate GlobeNewswire

Sep. 30, 2026

Immix Biopharma Announces Closing of $125 Million Underwritten Offering of Common Stock

Indeterminate GlobeNewswire

Sep. 30, 2026

WISeKey Reports First Half 2026 Financial Results, Accelerates Quantum and Post-Quantum Strategy and Provides Outlook

Indeterminate GlobeNewswire

Sep. 30, 2026

Blaize Announces Restructuring Plan to Focus Resources on Core Growth Areas

Indeterminate GlobeNewswire

Sep. 30, 2026

TAPI (Technology & API Services) Names Serge Rogasik CEO to lead next chapter of growth and competitiveness

Indeterminate GlobeNewswire

Sep. 30, 2026

Tevogen Regains Compliance with Nasdaq Global Market Continued Listing Requirements

Indeterminate GlobeNewswire

Sep. 30, 2026

Pliant Therapeutics Appoints David Raben, M.D., as Chief Medical Officer

Indeterminate GlobeNewswire

Sep. 30, 2026

Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026

Indeterminate GlobeNewswire

Sep. 30, 2026

Abivax présentera des données sur l’obéfazimod lors de l’United European Gastroenterology (UEG) Week 2026

Indeterminate GlobeNewswire

Sep. 30, 2026

Progress Software Reports Fiscal Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Sep. 30, 2026

Longeveron to Participate in Three Longevity/Aging Investment Conferences

Indeterminate GlobeNewswire

Sep. 30, 2026

Atsena Presents Positive 18-Month Results from Part A of the Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis

Indeterminate GlobeNewswire